Avoid investigations such as imaging, blood tests, endoscopies, etc., in cancer patients when the likelihood of and impact on treatment or disease management is low

31. JULI 2025

Rationale:

Any examination can be a burden for seriously ill patients. Therefore, the indication must be carefully considered.

References:

Fisher DA, et al. Inappropriate colorectal cancer screening: findings and implications. Am J Gastroenterol. 2005 Nov;100(11):2526-30. PMID: 16279910.
Lee SJ, et al. Time lag to benefit after screening for breast and colorectal cancer: meta-analysis of survival data from the United States, Sweden, United Kingdom, and Denmark. BMJ. 2013 Jan 8;346:e8441. PMID: 23299842.
Moyer VA. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012 Jul 17;157(2):120-34. PMID: 22801674.
Schroder FH, et al. Prostate-cancer mortality at 11 years of follow-up. N Engl J Med. 2012 Mar 15;366(11):981-90. PMID: 22417251.
Nasjonale faglige retningslinjer (Helsedirektoratet.no)

Avoid investigations such as imaging, blood tests, endoscopies, etc., in cancer patients when the likelihood of and impact on treatment or disease management is low.